239 related articles for article (PubMed ID: 32472525)
41. [Light chain amyloidosis].
Hegenbart U; Aus dem Siepen F; Schönland S
Inn Med (Heidelb); 2023 Sep; 64(9):842-847. PubMed ID: 37540260
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis and treatment of AL amyloidosis.
Sezer O; Eucker J; Jakob C; Possinger K
Clin Nephrol; 2000 Jun; 53(6):417-23. PubMed ID: 10879660
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies.
Nasr SH; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Lacy M; Dispenzieri A; Rajkumar SV; Kyle RA; Leung N
Am J Kidney Dis; 2012 Jun; 59(6):786-94. PubMed ID: 22417785
[TBL] [Abstract][Full Text] [Related]
44. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
[TBL] [Abstract][Full Text] [Related]
45. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.
Leung N; Dispenzieri A; Lacy MQ; Kumar SK; Hayman SR; Fervenza FC; Cha SS; Gertz MA
Clin J Am Soc Nephrol; 2007 May; 2(3):440-4. PubMed ID: 17699449
[TBL] [Abstract][Full Text] [Related]
46. The value of screening biopsies in light-chain (AL) and transthyretin (ATTR) amyloidosis.
Cohen OC; Sharpley F; Gilbertson JA; Wechalekar AD; Sachchithanantham S; Mahmood S; Whelan CJ; Martinez-Naharro A; Fontana M; Lachmann HJ; Hawkins PN; Gillmore JD
Eur J Haematol; 2020 Sep; 105(3):352-356. PubMed ID: 32495369
[TBL] [Abstract][Full Text] [Related]
47. Using digital whole-slide images to evaluate renal amyloid deposition and its association with clinical features and outcomes of AL amyloidosis.
Fan Y; Liang D; Rui H; Xu F; Xia Y; Yang F; Liang S; Zhu X; Zhang M; Huang X; Zeng C
J Nephrol; 2021 Oct; 34(5):1747-1756. PubMed ID: 33651314
[TBL] [Abstract][Full Text] [Related]
48. Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation.
Sidiqi MH; Aljama MA; Jevremovic D; Morice WG; Timm M; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Gonsalves WI; Kumar S; Kapoor P; Kourelis T; Leung N; Hogan WJ; Gertz M
Haematologica; 2018 Jul; 103(7):1229-1234. PubMed ID: 29674497
[TBL] [Abstract][Full Text] [Related]
49. Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.
Badar T; Cornelison AM; Shah ND; Bashir Q; Parmar S; Patel K; Hosing C; Popat U; Weber DM; Thomas SK; Shah JJ; Orlowski RZ; Champlin RE; Qazilbash MH
Eur J Haematol; 2016 Oct; 97(4):342-7. PubMed ID: 26773409
[TBL] [Abstract][Full Text] [Related]
50. [The importance of cardiac bio-marker assay for the stratification and monitoring of AL amyloidosis patients - single center experience].
Pika T; Lochman P; Vymětal J; Metelka R; Flodr P; Minařík J; Látalová P; Zapletalová J; Bačovský J; Sčudla V
Vnitr Lek; 2013 Sep; 59(9):776-81. PubMed ID: 24073949
[TBL] [Abstract][Full Text] [Related]
51. A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis.
Yao Y; Wang SX; Zhang YK; Qu Z; Liu G; Zou WZ
Nephrol Dial Transplant; 2013 Mar; 28(3):689-97. PubMed ID: 23182813
[TBL] [Abstract][Full Text] [Related]
52. Clinical outcomes and survival in AA amyloidosis patients.
Ayar Y; Ersoy A; Oksuz MF; Ocakoglu G; Vuruskan BA; Yildiz A; Isiktas E; Oruc A; Celikci S; Arslan I; Sahin AB; Güllülü M
Rev Bras Reumatol Engl Ed; 2017; 57(6):535-544. PubMed ID: 29173691
[TBL] [Abstract][Full Text] [Related]
53. [Renal amyloidosis].
Kościelska M; Shebani Z; Matuszkiewicz-Rowińska J
Przegl Lek; 2013; 70(4):205-10. PubMed ID: 23991559
[TBL] [Abstract][Full Text] [Related]
54. Cardiac Amyloidosis Presenting with Pre-Excitation Syndrome, Heart Failure, and Severe Factor X Deficiency as Part of Systemic Amyloid Light-Chain (AL) Amyloidosis - A Fatal Combination.
Almasri H; Almeer A; Awouda S; Hamid O; Sardar S; Anwer Z; Ibrahim F; Soliman D; Kandathil Y; Abu-Tineh M; Alabdul Razzak I; Alazawi SH
Am J Case Rep; 2021 Aug; 22():e933398. PubMed ID: 34413281
[TBL] [Abstract][Full Text] [Related]
55. Kidney and liver involvement in monoclonal light chain disorders.
Pozzi C; Locatelli F
Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397
[TBL] [Abstract][Full Text] [Related]
56. Association between clinical characteristics and AL amyloid deposition in the kidney.
Itabashi M; Takei T; Tsukada M; Sugiura H; Uchida K; Tsuchiya K; Honda K; Nitta K
Heart Vessels; 2010 Nov; 25(6):543-8. PubMed ID: 20922533
[TBL] [Abstract][Full Text] [Related]
57. Localized tongue amyloidosis: a single institutional case series.
O'Reilly A; D'Souza A; Lust J; Price D
Otolaryngol Head Neck Surg; 2013 Aug; 149(2):240-4. PubMed ID: 23715681
[TBL] [Abstract][Full Text] [Related]
58. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body
Ehman EC; El-Sady MS; Kijewski MF; Khor YM; Jacob S; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Falk RH; Hyun H; Dorbala S
J Nucl Med; 2019 Sep; 60(9):1234-1239. PubMed ID: 30954943
[TBL] [Abstract][Full Text] [Related]
59. Solid Organ Transplantation in Amyloidosis.
Theodorakakou F; Fotiou D; Dimopoulos MA; Kastritis E
Acta Haematol; 2020; 143(4):352-364. PubMed ID: 32535598
[TBL] [Abstract][Full Text] [Related]
60. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
